These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31675687)

  • 21. Development of a Novel Immune Infiltration-Based Gene Signature to Predict Prognosis and Immunotherapy Response of Patients With Cervical Cancer.
    Yu S; Li X; Zhang J; Wu S
    Front Immunol; 2021; 12():709493. PubMed ID: 34539641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Pan-Cancer Compendium of Genes Deregulated by Somatic Genomic Rearrangement across More Than 1,400 Cases.
    Zhang Y; Yang L; Kucherlapati M; Chen F; Hadjipanayis A; Pantazi A; Bristow CA; Lee EA; Mahadeshwar HS; Tang J; Zhang J; Seth S; Lee S; Ren X; Song X; Sun H; Seidman J; Luquette LJ; Xi R; Chin L; Protopopov A; Li W; Park PJ; Kucherlapati R; Creighton CJ
    Cell Rep; 2018 Jul; 24(2):515-527. PubMed ID: 29996110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-wide analysis of esophageal adenocarcinoma yields specific copy number aberrations that correlate with prognosis.
    Frankel A; Armour N; Nancarrow D; Krause L; Hayward N; Lampe G; Smithers BM; Barbour A
    Genes Chromosomes Cancer; 2014 Apr; 53(4):324-38. PubMed ID: 24446147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic identification of lincRNA-based prognostic biomarkers by integrating lincRNA expression and copy number variation in lung adenocarcinoma.
    Wang L; Zhao H; Xu Y; Li J; Deng C; Deng Y; Bai J; Li X; Xiao Y; Zhang Y
    Int J Cancer; 2019 Apr; 144(7):1723-1734. PubMed ID: 30226269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients.
    Li X; Tian R; Gao H; Yang Y; Williams BRG; Gantier MP; McMillan NAJ; Xu D; Hu Y; Gao Y
    Sci Rep; 2017 Nov; 7(1):16495. PubMed ID: 29184082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amplified genes may be overexpressed, unchanged, or downregulated in cervical cancer cell lines.
    Vazquez-Mena O; Medina-Martinez I; Juárez-Torres E; Barrón V; Espinosa A; Villegas-Sepulveda N; Gómez-Laguna L; Nieto-Martínez K; Orozco L; Roman-Basaure E; Muñoz Cortez S; Borges Ibañez M; Venegas-Vega C; Guardado-Estrada M; Rangel-López A; Kofman S; Berumen J
    PLoS One; 2012; 7(3):e32667. PubMed ID: 22412903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Classification of HER2-negative breast cancers by
    Loh JW; Lim AH; Chan JY; Yap YS
    Ther Adv Med Oncol; 2023; 15():17588359231206259. PubMed ID: 37920257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer.
    Liu N; Wu Y; Cheng W; Wu Y; Wang L; Zhuang L
    BMC Cancer; 2021 Apr; 21(1):460. PubMed ID: 33902514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysis.
    Thiesen HJ; Steinbeck F; Maruschke M; Koczan D; Ziems B; Hakenberg OW
    PLoS One; 2017; 12(5):e0176659. PubMed ID: 28486536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The functional consequences and prognostic value of dosage sensitivity in ovarian cancer.
    Yan Z; Liu Y; Wei Y; Zhao N; Zhang Q; Wu C; Chang Z; Xu Y
    Mol Biosyst; 2017 Jan; 13(2):380-391. PubMed ID: 28067383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic, immunological and single-cell features of m6A molecules in cervical cancer.
    Zhu X; Song X; Chen Q; Peng Y; Shi F
    Cell Mol Biol (Noisy-le-grand); 2023 Sep; 69(9):89-99. PubMed ID: 37807329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer driver gene discovery through an integrative genomics approach in a non-parametric Bayesian framework.
    Yang H; Wei Q; Zhong X; Yang H; Li B
    Bioinformatics; 2017 Feb; 33(4):483-490. PubMed ID: 27797769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.
    Curtis C; Shah SP; Chin SF; Turashvili G; Rueda OM; Dunning MJ; Speed D; Lynch AG; Samarajiwa S; Yuan Y; Gräf S; Ha G; Haffari G; Bashashati A; Russell R; McKinney S; ; Langerød A; Green A; Provenzano E; Wishart G; Pinder S; Watson P; Markowetz F; Murphy L; Ellis I; Purushotham A; Børresen-Dale AL; Brenton JD; Tavaré S; Caldas C; Aparicio S
    Nature; 2012 Apr; 486(7403):346-52. PubMed ID: 22522925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive analysis of copy number aberrations in microsatellite stable colon cancer in view of stromal component.
    Alonso MH; Aussó S; Lopez-Doriga A; Cordero D; Guinó E; Solé X; Barenys M; de Oca J; Capella G; Salazar R; Sanz-Pamplona R; Moreno V
    Br J Cancer; 2017 Jul; 117(3):421-431. PubMed ID: 28683472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.
    Zeng Y; Wang KX; Xu H; Hong Y
    J Cell Biochem; 2018 Feb; 119(2):1558-1566. PubMed ID: 28771797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The repertoire of copy number alteration signatures in human cancer.
    Tao Z; Wang S; Wu C; Wu T; Zhao X; Ning W; Wang G; Wang J; Chen J; Diao K; Chen F; Liu XS
    Brief Bioinform; 2023 Mar; 24(2):. PubMed ID: 36806386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival differences of CIMP subtypes integrated with CNA information in human breast cancer.
    Wang H; Yan W; Zhang S; Gu Y; Wang Y; Wei Y; Liu H; Wang F; Wu Q; Zhang Y
    Oncotarget; 2017 Jul; 8(30):48807-48819. PubMed ID: 28415743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Copy-number analysis identified new prognostic marker in acute myeloid leukemia.
    Nibourel O; Guihard S; Roumier C; Pottier N; Terre C; Paquet A; Peyrouze P; Geffroy S; Quentin S; Alberdi A; Abdelali RB; Renneville A; Demay C; Celli-Lebras K; Barbry P; Quesnel B; Castaigne S; Dombret H; Soulier J; Preudhomme C; Cheok MH
    Leukemia; 2017 Mar; 31(3):555-564. PubMed ID: 27686867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Copy number losses of oncogenes and gains of tumor suppressor genes generate common driver mutations.
    Besedina E; Supek F
    Nat Commun; 2024 Jul; 15(1):6139. PubMed ID: 39033140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.